Drug intelligence / Profile preview

14,15-epoxyeicosatrienoic acid

Development stage
Preclinical
Lead developer
OMM Scientific
Modality
Small Molecules
Administration
Oral
01

Overview

14,15-epoxyeicosatrienoic acid (14,15-EET) is a bioactive lipid metabolite of arachidonic acid, synthesized primarily by cytochrome P450 (CYP) epoxygenases. As a member of the epoxyeicosatrienoic acid family, it functions as an autocrine and paracrine signaling molecule with significant roles in cardiovascular and renal physiology. 14,15-EET is recognized as an endothelium-derived hyperpolarizing factor (EDHF) that induces vasodilation by activating large-conductance calcium-activated potassium (BK) channels in vascular smooth muscle cells. Additionally, it exhibits anti-inflammatory, anti-apoptotic, and cardioprotective properties, often mediated through the activation of peroxisome proliferator-activated receptors (PPARs). OMM Scientific provides the racemic (±) form of 14,15-EET as a research reagent for preclinical investigation into eicosanoid signaling pathways and their potential therapeutic applications in hypertension, inflammation, and metabolic disorders.

Other names
±14,15-epoxyeicosatrienoic acid(±)14,15-EET14,15-epoxy-5Z,8Z,11Z-eicosatrienoic acidracemic 14,15-epoxyeicosatrienoic acid
02

Targets

EP3-IV (Prostaglandin E receptor 3 isoform 4)KCNMA1 (Calcium-activated potassium channel subfamily M alpha member 1)PTGER2 (Prostaglandin E2 receptor EP2)PTGFR (Prostaglandin F2 alpha receptor)PTGDR (Prostanoid DP1 receptor)KATP channel (ATP-sensitive potassium channel)PTGER4 (Prostaglandin E2 receptor EP4 subtype)TRPV4 (Transient receptor potential cation channel subfamily V member 4)

Beyond the preview

Go deeper on 14,15-epoxyeicosatrienoic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 14,15-epoxyeicosatrienoic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call